Idex stock
Price history
+34.75% over the period1 year: from $163.00 (November 20, 2025) to $219.64 (November 20, 2026), +34.75%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | $219.64 |
| October 30, 2026 | $233.84 |
| September 30, 2026 | $227.98 |
| August 31, 2026 | $228.64 |
| July 31, 2026 | $230.45 |
| June 30, 2026 | $226.95 |
| May 29, 2026 | $210.83 |
| April 30, 2026 | $217.85 |
| March 31, 2026 | $189.55 |
| February 27, 2026 | $209.47 |
| January 30, 2026 | $198.55 |
| December 31, 2025 | $177.94 |
| November 28, 2025 | $173.93 |
| November 20, 2025 | $163.00 |
At a glance
The company
Manufactures precision fluidics, pumps, sealing solutions, medical devices, flow control equipment and firefighting systems across health, fluid handling and safety applications
Latest results
Quarter to September 30, 2026 · EPS $2.33 (estimate $2.24)
Dividend
TickerLandia's take on Idex
- Priced as usual relative to earnings: P/E on the latest fiscal year 34 vs a median of 30 over its last 10 fiscal years.
- Priced in line with similar companies: trailing 12-month P/E 31 vs 31 (−2%) in a group of 11.
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−9.91% from the 52-week high
Analysts · 15 analysts
Average target$262.93+19.71% vs. price
Buy 10 · Hold 5 · Sell 0 · Buy
TickerLandia Fingerprint: Idex
Compared with similar companies: low risk, high profitability, and strong momentum.
Financials and price compared with 94 companies in the specialty industrial machinery industry, worldwide. Momentum and risk compared with 888 North American stocks.
Pricehigh63
How much it costs relative to what it produces.
Metric Value Position in group EV/EBITDA 17.4 61 P/E (trailing 12 months) 30.5 66 Forward P/E 22.3 65 Price/book 4.03 49 Price/sales 4.41 74 Profitabilityhigh65
How much it earns on revenue and capital.
Metric Value Position in group Net margin 14.6% 72 ROE 13.3% 42 ROA 7.1% 58 Gross margin 44.9% 73 Operating margin 21.4% 79 Earnings stabilityhigh63
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 1.5% 67 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 59 Growthaverage45
How fast revenue and earnings are growing.
Metric Value Position in group Revenue growth (year over year) +8.30% 46 Earnings growth (year over year) +14.70% 49 Average revenue growth (3 years) +2.81% 40 Financial strengthaverage47
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Debt/equitycounts in reverse: lower means more financial strength 0.44 41 Net debt/EBITDAcounts in reverse: lower means more financial strength 1.46 26 Interest coverage 11.3 33 Current ratio 2.78 90 Dividendaverage55
How much it returns to shareholders, and for how long.
Metric Value Position in group Dividend yield 1.3% 37 Payout ratio 40.3% 48 Consecutive dividend years 32 years 80 Market momentumstrong65
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +3.90% 53 1-year return +34.75% 83 Distance from 200-day average +0.41% 59 Relative strength (6 months) +13.48% 65 Risklow28
How much the price swings.
Metric Value Position in group Volatility (60 days) 23.8% 19 Maximum drawdown (12 months) 14.5% 8 Beta (1 year) 0.78 55
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Idex is priced as in the past and in line with similar companies
On the latest fiscal year's earnings (2025), Idex's P/E today is 34.3, in line with the median of its last 10 fiscal years (29.9; between 23.9 and 40.3 from 2016 to 2025). Idex's P/E (trailing 12 months): 30.5, in line with the median of a group of 11 similar companies (31.1).
Compared with 11 similar companies
| Metric | Idex | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 30.5 | Middle | |
| Forward P/E | 22.3 | Middle | |
| Operating margin | 21.4% | High | |
| ROE | 13.3% | Middle | |
| Debt/equity | 0.44 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Idex. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$951.7M
Latest quarter · Q3 2026
Net income
$144.1M
Latest quarter · Q3 2026
Quarterly net margin
15.1%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- $16.13B
- P/E
- 30.5
- EPS
- $7.20
- Volume
- 760.18K
- Daily trading
- €168.84M
- Dividend yield
- 1.32%
How Idex is changing
All resultsRevenue grew 8.0% a year on average over the last 5 years
Operating margin fell from 23.6% to 20.2%
Profits turn into cash: free cash flow equal to 117% of net income
Returns
Idex returns with dividends
$1,000 invested in Idex 5 years ago, on November 22, 2021, would be worth $996 today with dividends reinvested: −0.39% in total, −0.08% per year. On price alone it would be $933 (−6.66%).
| Period | Idex | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | −5.80% | −10.40% | $942 |
| 6 months | +5.50% | −7.03% | $1,055 |
| Year to date | +23.43% | +0.95% | $1,234 |
| 1 year | +36.58% | +5.68% | $1,366 |
| 3 years | +16.97% | +51.96% | $1,170 |
| 5 years | −0.39% | +47.57% | $996 |
| 10 years | +168.97% | +214.37% | $2,690 |
Over the last 6 months it has done better than 77% of the stocks in the Industrials sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment
The chart in detail
Idex: technical analysis
Idex shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 10.7% below its highest close since January 2, 1990 ($245.87, March 21, 2024).
- Trend
- No clear trend
- RSI (14 sessions)
- 36
- Between 30 and 70
- vs 200-session average
- +0.41%
Active signals
Close below the low of the previous 20 sessions.
Support and resistance
Price areas where Idex has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$241.64+10.02%6 touches, last on November 11, 2026
- Resistance$230.94+5.14%2 touches, last on July 17, 2026
- Resistance$223.47+1.74%4 touches, last on November 5, 2026
- Last price$219.64
- Support$217.64−0.91%4 touches, last on September 16, 2026
- Support$211.44−3.73%3 touches, last on June 11, 2026
- Support$203.10−7.53%4 touches, last on May 20, 2026
Volatility and risk
Over the last year it has moved less than the S&P 500.
- Beta (1 year) vs S&P 500
- 0.78
- Volatility (60 sessions, annualised)
- 23.8%
- Largest fall in the last year
- −14.49%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Idex: seasonality
Average monthly price change over 37 years
Over the last 37 years, the strongest month for Idex has been November: +4.59% on average, positive in 32 years out of 36. The weakest has been August: −1.69% on average, positive in 14 years out of 37.
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +0.28% | −1.97% | 16 of 36 |
| February | +1.12% | +2.46% | 26 of 37 |
| March | +1.62% | +2.15% | 23 of 37 |
| April | +4.58% | +3.24% | 26 of 37 |
| May | +1.46% | +2.22% | 25 of 37 |
| June | +1.38% | +0.33% | 20 of 37 |
| July | +0.93% | +1.54% | 20 of 37 |
| August | −1.69% | −0.79% | 14 of 37 |
| September | −1.10% | −0.74% | 14 of 37 |
| October | +1.67% | +2.57% | 26 of 37 |
| November | +4.59% | +4.53% | 32 of 36 |
| December | +1.51% | +2.41% | 24 of 36 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Idex and its competitors
Sales of IDEX Corporation are spread across the United States, which accounts for 50.9% of revenue, Europe with 24.5%, Asia with 16.3%, North America excluding the United States with 3.8% and other areas with 4.8%. Operating through subsidiaries, the company runs three segments. Health & Science Technologies covers precision fluidics, positive displacement pumps, drying systems, sealing components, medical devices, optical components and photonic solutions.
- Headquarters
- Northbrook, United States
- Employees
- 8,700
- Founded
- 1987
- Chief executive
- Eric Ashleman
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| IdexIEX | $16.13B | 21.4% | 30.5 | +5.50% |
| NordsonNDSN | $17.12B | 27.2% | 31.1 | +11.23% |
| ITTITT | $17.94B | 15.9% | 41.4 | +4.01% |
| SymboticSYM | $18.83B | 0.5% | 388.8 | −37.75% |
| XylemXYL | $21.71B | 15.5% | 21.0 | −12.53% |
| Crane CompanyCR | $11.69B | 17.7% | 34.7 | +16.56% |
Same industry or related industries, similar size. Compare Idex with its competitors · Full profile
